Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Biomed Environ Sci ; 8(3): 265-8, 1995 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-8561927

RESUMO

A better understanding is needed to explain the mechanism of therapeutic effect of combined use of tetradrine-PVNO and tetradrine-QOHP which play very important roles in treatment of silicosis. Blood prolidase (PLD), monamine oxidase (MAO) and plasminogen (PLG) in silicotic rats after treatment with tetradrine-PVNO or tetradrine-QOHP were measured. The values obtained were compared with the untreated silicotic rats. It was found that the silicotic rats that received tetradrine-PVNO showed significant increase in PLD and decrease in PLG, but no significant change in MAO. The PLD in plasma of silicotic rats that received tetradrine-QOHP were elevated significantly, but PLG and MAO did not change appreciably. These findings suggest that the combined use of tetradrine-PVNO and tetradrine-QOHP can accelerate the degradation of collagen in silicotic rats.


Assuntos
Alcaloides/uso terapêutico , Benzilisoquinolinas , Piperazinas/uso terapêutico , N-Óxido de Polivinilpiridina/uso terapêutico , Silicose/tratamento farmacológico , Alcaloides/administração & dosagem , Animais , Dipeptidases/sangue , Masculino , Monoaminoxidase/sangue , Piperazinas/administração & dosagem , Plasminogênio/metabolismo , N-Óxido de Polivinilpiridina/administração & dosagem , Ratos , Ratos Wistar , Silicose/sangue , Silicose/enzimologia , Silicose/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...